Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil

Medical Mycology

Volumn 46, Issue 2, 2008, Pages 141-151

  Galhardo, Maria Clara Gutierrez ^a   De Oliveira, Rosely Maria Zancopé ^a   Do Valle, Antonio Carlos Francesconi ^a   De Almeida Paes, Rodrigo ^a   Silvatavares, Patricia Morais ^a   Monzon, Araceli ^b   Mellado, Emilia ^b   Rodriguez Tudela, Juan ^b   Cuenca Estrella, Manuel ^b  

^a Funda??o Oswaldo Cruz   (Brazil)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Clinical forms; In vitro susceptibility; ITS region; PCR fingerprinting; Sporothrix schenckii

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FUNGAL DNA; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; POSACONAZOLE; RAVUCONAZOLE; RIBOSOME DNA; TERBINAFINE; VORICONAZOLE;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BRAZIL; CAT; CONTROLLED STUDY; DNA FINGERPRINTING; DNA SEQUENCE; EPIDEMIC; FEMALE; FUNGAL STRAIN; FUNGUS ISOLATION; GENETIC SIMILARITY; GENOTYPE; HUMAN; HYPERTHERMIC THERAPY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; SCHOOL CHILD; SEQUENCE ANALYSIS; SPAIN; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS; STRAIN DIFFERENCE; ZOONOSIS;

ANIMALS; ANTIFUNGAL AGENTS; BRAZIL; CATS; DNA, RIBOSOMAL SPACER; EPIDEMIOLOGY, MOLECULAR; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES; SPOROTHRIX; SPOROTRICHOSIS; ZOONOSES;

SPOROTHRIX SCHENCKII;

EID: 40649110334     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780701742399     Document Type: Article

References (40)

1. Rippon, J. (1988) Sporotrichosis. Medical Mycology - The Pathogenic Fungi and Pathogenic Actinomycetes, pp. 325-352. W. B. Saunders Company, Philadelphia
2. Diaz, IA. Conti (1989) Epidemiology of sporotrichosis in Latin America. Mycopathologia, 108, pp. 113-116.
3. Kwon-Chung, KJ and Bennet, JE. (1992) Sporotrichosis. Medical Mycology, pp. 707-729. Lea & Febiger, Philadelphia
4. Kauffman, CA, Hajjeh, R. and Chapman, SW. (2000) Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America. Clin Infect Dis, 30, pp. 684-687.
5. Silva-Vergara, ML, Maneira, FR and De Oliveira, RM (2005) Multifocal sporotrichosis with meningeal involvement in a patient with AIDS. Med Mycol, 43, pp. 187-190.
6. Stephenson, I., Jenkins, DR, Wiselka, MJ, Hardman, S. and Johnson, EM. (2005) Disseminated Sporothix schenckii in a patient with AIDS. J Infect, 51, pp. 73-77.
7. Ishizaki, H., Kawasaki, M., Aoki, M. and Matsumoto, T. (1998) Mitochondrial DNA analysis of Sporothrix schenckii in North and South America. Mycopathologia, 142, pp. 115-118.
8. Ishizaki, H., Kawasaki, M., Aoki, M., Vismer, H. and Muir, D. (2000) Mitochondrial DNA analysis of Sporothrix schenckii in South Africa and Australia. Med Mycol, 38, pp. 433-436.
9. Watanabe, S., Kawasaki, M., Mochizuki, T. and Ishizaki, H. (2004) RFLP analysis of the internal transcribed spacer regions of Sporothrix schenckii. Nippon Ishinkin Gakkai Zassh., 45, pp. 165-175.
10. Mesa-Arango, AC and Reyes-Montes, M Del Rocio (2002) Phenotyping and genotyping of Sporothrix schenckii isolates according to geographic origin and clinical form of Sporotrichosis. J Clin Microbiol, 40, pp. 3004-3011.
11. Neyra, E., Fonteyne, PA and Swinne, D. (2005) Epidemiology of human sporotrichosis investigated by amplified fragment length polymorphism. J Clin Microbiol, 43, pp. 1348-1352.
12. Arenas, R., Miller, D. and Campos-Macias, P. (2007) Epidemiological data and molecular characterization (mtDNA) of Sporothrix schenckii in 13 cases from Mexico. Int J Dermatol, 46, pp. 177-179.
13. Liu, X., Lian, C., Jin, L., An, L., Yang, G. and Lin, X. (2003) Characterization of Sporothrix schenckii by random amplification of polymorphic DNA assay. Chin Med J (Engl), 16, pp. 239-242.
14. da Rosa, AC, Scroferneker, ML and Vettorato, R. (2005) Epidemiology of sporotrichosis: A study of 304 cases in Brazil. J Am Acad Dermatol, 52, pp. 451-459.
15. Sampaio, SAP, Lacaz, CS and Almeida, F. (1954) Aspectos clínicos da esporotricose em SP-análise de 235 casos. Revista do Hospital das Clínicas, pp. 391-402.
16. Lopes, JO, Alves, SH and Mari, CR (1999) Epidemiology of sporotrichosis in the central region of Rio Grande do Sul. [Article in Portuguese]. Rev Soc Bras Med Trop, 32, pp. 541-545.
17. Fleury, RN, Taborda, PR and Gupta, AK (2001) Zoonotic sporotrichosis. Transmission to humans by infected domestic cat scratching: Report of four cases in São Paulo, Brazil. Int J Dermatol, 40, pp. 318-322.
18. Marques, SA, Franco, SR and de Camargo, RM (1993) Sporotrichosis of the domestic cat (Felis catus): Human transmission. [Article in Portuguese]. Rev Inst Med Trop Sao Paulo, 35, pp. 327-330.
19. Barros, MB, Schubach, A., de, O. and Valle, AC do (2004) Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: Description of a series of cases. Clin Infect Dis, 38, pp. 529-535.
20. Schubach, TM, Schubach, A. and Okamoto, T. (2004) Evaluation of an epidemic of sporotrichosis in cats: 347 cases (1998-2001). J Am Vet Med Assoc, 224, pp. 1623-1629.
21. Schubach, TM, Schubach, A. and Okamoto, T. (2006) Canine sporotrichosis in Rio de Janeiro, Brazil: Clinical presentation, laboratory diagnosis and therapeutic response in 44 cases (1998-2003). Med Mycol, 44, pp. 87-92.
22. Lopes-Bezerra, LM, Schubach, A. and Costa, RO. (2006) Sporothrix schenckii and sporotrichosis. An Acad Bras Cienc, 78, pp. 293-308.
23. Barros, MB de Lima, Schubach, A de Oliveira and Galhardo, MC (2003) Sporotrichosis with widespread cutaneous lesions: Report of 24 cases related to transmission by domestic cats in Rio de Janeiro, Brazil. Int J Dermatol, 42, pp. 677-681.
24. Schubach, A., Barros, MB de Lima and Schubach, TM (2005) Primary conjunctival sporotrichosis: Two cases from a zoonotic epidemic in Rio de Janeiro, Brazil. Cornea, 24, pp. 491-493.
25. Galhardo, MC Gutierrez, Schubach, A de Oliveira and Barros, MB de Lima (2002) Erythema nodosum associated with sporotrichosis. Int J Dermatol, 41, pp. 114-116.
26. Gutierrez-Galhardo, MC, Barros, MB and Schubach, AO (2005) Erythema multiforme associated with sporotrichosis. J Eur Acad Dermatol Venereol, 9, pp. 507-509.
27. Schubach, TM, Schubach, A de Oliveira and Reis, RS dos (2002) Sporothrix schenckii isolated from domestic cats with and without sporotrichosis in Rio de Janeiro, Brazil. Mycopathologia, 153, pp. 83-86.
28. Reis, RS, Schubach, TM, Guimarães, A., Monteiro, P. and Zancopé-Oliveira, R. Molecular typing of Sporothrix schenckii strains isolated from clinical speciments in Rio de Janeiro, Brazil.
29. Sampaio, SAP and Lacaz, CS. (1959) Klinische und statistiche Untersuchungen über Sporotrichose in Sao Paulo. Hautarzt, 10, pp. 490-493.
30. National Committee for Clinical Laboratory Standards Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. National Committee for Clinical Laboratory Standards, Wayne, PA
31. Holden, DW. (1994) DNA miniprep method for Aspergillus fumigatus (and other filamentous fungi). Molecular Biology of Pathogenic Fungi, pp. 3-4. Telos Press, New York
32. Meyer, W., Marszewska, K. and Amirmostofian, M. (1999) Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA-a pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis, 20, pp. 1790-1799.
33. Kohler, LM, Monteiro, PC, Hahn, RC and Hamdan, JS. (2004) In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine. J Clin Microbiol, 42, pp. 4319-4320.
34. McGinnis, MR, Nordoff, N., Li, RK, Pasarell, L. and Warnock, DW. (2001) Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B. Med Mycol, 39, pp. 369-371.
35. Trilles, L., Fernandez-Torres, B. and Lazera, M Dos Santos (2005) In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases. Antimicrob Agents Chemother, 49, pp. 3952-3954.
36. Chapman, SW, Pappas, P. and Kauffmann, C. (2004) Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Mycoses, 47, pp. 62-68.
37. Tachibana, T., Matsuyama, T. and Mitsuyama, M. (1999) Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol, 37, pp. 397-404.
38. Marimon, R., Gene, J. and Cano, J. (2006) Molecular phylogeny of Sporothrix schenckii. J Clin Microbiol, 44, pp. 3251-3256.
39. Tachibana, T., Matsuyama, T. and Mitsuyama, M. (1998) Characteristic infectivity of Sporothrix schenckii to mice depending on routes of infection and inherent fungal pathogenicity. Med Mycol, 36, pp. 21-27.
40. Kong, X., Xiao, T., Lin, J., Wang, Y. and Chen, HD. (2006) Relationships among genotypes, virulence and clinical forms of Sporothrix schenckii infection